Blackstone Inc’s Moderna MRNA Stock Holding History

Blackstone Inc’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,613	Closed	-$641K	–	621
2026 Q1	$641K	Hold	12,613	–	–	﹤0.01%	275
2025 Q4	$372K	Hold	12,613	–	–	﹤0.01%	234
2025 Q3	$326K	Hold	12,613	–	–	﹤0.01%	233
2025 Q2	$348K	Hold	12,613	–	–	﹤0.01%	153
2025 Q1	$358K	Hold	12,613	–	–	﹤0.01%	155
2024 Q4	$524K	Hold	12,613	–	–	﹤0.01%	145
2024 Q3	$843K	Buy	+12,613	New	+$1.16M	﹤0.01%	126

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Blackstone Inc's MRNA Position: Q2 2026 in Review

Blackstone Inc sold out of Moderna (MRNA) in Q2 2026, closing a stake of 12,613 shares — an estimated $641K sold.

Blackstone Inc first reported a position in MRNA in Q3 2024 and held it in 7 quarters. The position peaked at $843K in Q3 2024. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Blackstone Inc reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
Blackstone Inc sold 12,613 Moderna shares in Q2 2026, an estimated $641K.
Blackstone Inc first reported a position in Moderna in Q3 2024 and held it in 7 quarters.
Blackstone Inc's Moderna position peaked at $843K in Q3 2024.
775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.